The COVID-19 International Drug Pregnancy Registry (COVID-PR): Protocol Considerations. Wyszynski DF, Papageorghiou AT, Renz C, Metz TD, et al. Drug Saf 2024;47:195-204.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wyszynski DF, Papageorghiou AT, Renz C, Metz TD, et al. The COVID-19 International Drug Pregnancy Registry (COVID-PR): Protocol Considerations. Drug Saf 2024;47:195-204.
PMID: 37973784